Safety

News

Novo hopes data will boost new insulin in US and Germany

Novo Nordisk hopes that new data supporting the cardiovascular and glycaemic safety of its Tresiba long-acting insulin will prove a game-changer in the US.

News

J&J diabetes drug hit by amputation risk

Invokana produces modest CV benefit, but doubles risk of amputation

News

FDA makes unprecedented move, asks Endo to pull painkiller f...

Regulator concerned about potential abuse of Opana ER

News

abstract shapes, bone structure, 3d render, bone

Safety restrictions spell the end for Servier osteoporosis d...

Sales of Protelos hit by safety restrictions.

News

Brain infection would be bad news for Roche's MS drug Ocrevu...

Suggestion is that PML case was caused by previous treatment.

News

Doctors must be educated about opioid abuse, says FDA's Gott...

New FDA commissioner Scott Gottlieb has outlined his plans to tackle the opioid abuse epidemic afflicting the US, saying doctors should be better educated about the risks of prescribing mon